Table 1.
Target group | Data collection methods and sample size (planned respondents) |
Sampling strategy |
---|---|---|
National malaria control programme | 3 IDI | All personnel with key role in malaria case management strategy delivery |
Central essential drugs store (CAMEG) | 3 IDI | All personnel with key role in ACT ordering and inventory management |
North-central health region (Head of the health region, Lead pharmacist, Responsible of the disease control service) |
3 IDI | All personnel with key role in malaria case management strategy delivery |
Heath district management team of Kaya (Head of the health district, Lead pharmacist Responsible for the district-level healthcare provision) | 3 IDI | All personnel with key role in malaria case management strategy delivery |
Head of the local health facilities | 5 IDI, 4 FGD | 5 heads of the local health facilities in the health district of Kaya will be randomly selected and invited for the IDI. The 40 heads of local health facilities will be allocated randomly into for groups for FGD |
Essential drugs stores managers at health facilities level | 5 IDI, 4 FGD | 5 essential drugs store keepers of the local health facilities in the health district of Kaya will be randomly selected and invited for the IDI. The 40 essential drugs store keepers of local health facilities will be allocated randomly into for groups for FGD |
Local health workers | 10 FGD |
10 local health facilities in the health district of Kaya will be randomly selected and the local health workers in charge of malaria case management in pregnant women, children under five and individuals of five years old and above will be grouped for the conduct of the FGD |
ACT artemisinin-based combination therapy; FGD focus group discussion; IDI in-depth individual interviews